Alu Overexpression Leads to an Increased Double‐Stranded RNA Signature in Dermatomyositis
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.43328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Rayan Najjar und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington, Seattle. Hauptthemen laut MEDLINE: Dermatomyositis, Alu Elements, RNA, Double-Stranded. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective Dermatomyositis is an autoimmune condition characterized by a high interferon signature of unknown etiology. Because coding sequences constitute
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Washington, Seattle.
- National Institute of Arthritis and Musculoskeletal and Skin Disease, NIH, Bethesda, Maryland.
ORCID-Profile: Rayan Najjar, Andrew Mammen, Tomas Mustelin
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Najjar, R., Mammen, A., & Mustelin, T. (2026). Alu Overexpression Leads to an Increased Double‐Stranded RNA Signature in Dermatomyositis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43328
Vancouver
Najjar R, Mammen A, Mustelin T. Alu Overexpression Leads to an Increased Double‐Stranded RNA Signature in Dermatomyositis. Arthritis & Rheumatology. 2026. doi:10.1002/art.43328
BibTeX
@article{Najjar2026,
author = {Najjar, Rayan and Mammen, Andrew and Mustelin, Tomas},
title = {Alu Overexpression Leads to an Increased Double‐Stranded RNA Signature in Dermatomyositis},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.43328}
}
EUVIMED